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BACKGROUND: AEROBIC MICROFlORA OF THE TONSIL Table 2 EHect of preoperatrve antibiotic treotment on care Ions" flora [6]
Table 1 Arabic bacte"ology of the 10nsII co,e 111 122 paliel1ls [1.2]
'49/122 (40 16%) of looslls cOnJlIlI1od ana 0' more r\ laClamaso
producers Modlfood from Table 1 111 (3]
Th.: pJlhog':lIe'l> of r.:currellt JClll,' colhlllJtls (itAT) IS uncl,'.lr
,lI1d we Pll\tlll;ll.:d tlut 1Il patl.:nt wllh Ihl~ ('( ndmon, hJ tl'n~
pre'<'m 111 rll<' lUlISLl ClIl,' (otllt'r th,llI Croup A 13HS) lIl~y h,1w
,I !,athog"11l r I In ;1 study covering rwo t1l11<: penods III
years apart [II, w h~d found th~t l1l clllldn:1I ami adults with
ItAT, th.: toml11s ,I re'.:rVOIr o( I [,//'I/II'l'lIilm i,!/]///'II::-lIf (T~hlc
1). The .1s'C>ClanOI1 llf II. "!fl"mz If With itA IS al1alogous m
thl' 1111dlllb'" (1'0111 ~dl'llllld tissu,' III chlldrl'n wIth Jdeuol,bl
hypl'rtrophy, 11111'11/"/,1,,111$ U!(lW'U':,'f ,r.r;um Isolated were
lnm:ally nOIll)'p,lhll' ,Illd l1oucapsulated, Thet'e wa~ .1 poor
ass ci.1tiou betweeu "n ble haLtenoloro' of ,I superficial [()u.,il
"",,1> and the toml1 core r1.21. whl h was . inllbr to thl'
lilldlng.~ or Olher ,H1thors [4.51. ,'perfomled ~ stud' to
det... mlllle whether or not or.U .umbiotlcs pencrr.uc the
dll,'a.ed tOllsil and lI1(luence rhe ort' tonsLl flora. he 1I111'.1et
of 7 Jay, I'reopt'r.Hiw ,1ntlblOnC on the ~eroblc bactena]
·om...m of the wmil III 70 COllllTlltivl' p~cielm 'hedulcd fur
101'-~IU':Ctol1lY bl'(aIlS" of RAT wa Itudied [(,J. 130th
,I11l0XyCllllll anJ celJdor, ,'ach ,ldlllll1lstered for 7 days
I'r 'IOmlllccwllly. rt'dllced the aerobIC bacterial olltent of
lh,' ron.,11 wlll'1I rOlllpart'd with all untreated control groul'.
he Illmr 'l.lOlti ,Illy ih'l11fic.IJIl ,lJfler<:ncc \\'as hetween the
Numbor HI lactamase
producers) ,
Group 1. Group 2. Group 3.
1I0no cafaclor amoxycillin
n 23 21 20
TOlal bacteroal counl
Mcan ( , 10s ) 365 4.01 109B
Range ( ~ lOS) 1 0-160 01-30 01 50
ANO~". F - 21 6, d I., 2 61. P _ 0 001
l-tBst group 1 vs group 2. 1- 631. group 1 vs group 3. r - 4.42.
group 2 vs group 3, I - 1 83
IlIltre~t...d ollrrol grout' aud rhe cd-:,e1or rrcat<'ll group 161
(Table 2). \Ve conclude Ih, I .1t1tibi nn c, II I'ellerr.lt... tht'
dl,e~scd 1011111 .111.1 inl1u ... llcl' the core rollsil I11lcrol1ora.
h,' value of pemasal sw, b.. lJl ,1 '<.''I.~ll1g the aerobll
h~rtt:ri lo!-.'Y 111 children and ~dult3 wllh 1',' UITem aClltl'
tonsilIim, and In children wlrh "hromc adl.'nOldal and
ad,'notOllSlllar JISC, ~t', wal asl<,";scd til 175 p311en [7J The
f(roup scudlt' I II1duJeJ patient underKomg tollSllJ,' tomy
adenoidc tolll)' (II = 122), rOlmlleclOlI1Y .lIon... (II = 12) and
,Idenoide tol11Y alone (II = ,II). A 'lIl'erfi IJI throat IW,lh
prediCl"d till' aerobic path l-:en. present ill the 10III II cor... III
34% of p~tienr . Th,'''' was a e1me reiati0ll5111p helween rhe
baClenolo~lcalfil1dm~ trom pemasal and ronsil core III 71°/., o(
patll'llts, mcllldll1~ 44,7% III whICh thl' pathogen profile was
idenncal. here, ,1.1 a LInse r.:buomhJp belween tile ,lcr bte
bacrerinlo!-.'Y () the pl'masal ..wab and th.. adenllld:d tl~lUe/
[olllil core in 72%/71 % l ( p. ticn~, r(~l'ecnve1 , WIth JIl
Identical profil,' of p, thog"'l15 in -2%/4Q"{,. One or mar.:
Ollllllon pathogen. weI'" Isobll'J from tomil .lIld prena\al
swab 111 71 % of case.. , WIth an Idl'nno:a] pathogenIC profile III
45"1. \71. When rhe ha tenol0ro' or tOI1.! II all I .lden ld \Va,
omp'lrcd, tlll'r,' was ,I ommon p~thogt:n 111 ')2% ,n I 311
lllemic,ll pathogenic prolile in 70% of c,l~es [71. l veralJ from
tonSIl .1.nd/nr adenOId H, i'!f1I1~lIzar wa' the rnml frequem
isolate, obtailled fmlll 7R% of ,ld,'noid ..amp!.:, and 72"{' o(
ron~ils 12.71. 1-lflI''''''I,ltilll.l ,',!(I'WI/zar and Srlll'hyIOf" (Jr._ <lim,,!














fl homolytiC slreptOcoccus Group A. C, or G
Srroplococcus pnoumonwo
Mora_elln cDlDrrhs!Js
Number wllh m,xed pmhogens
Upper resp"Alory commensal flora only
Pathogen Isolated
Corr,'Spondllll: authur Jlld rqlt'llll l'c'l"e L"
ROl1lllda Hn<, IIJI. D"hllll. Ireland
Tel.: 353 I H7J 11700
F.I,~: 35) I K72 (9)lJ
( 2000 Copyllghl by Itl Europenn SoclOIV 01 Chnlcal Microbiology anri InteclloU5 0'5005 5 eMI, 6 (Suppl 3) 59-'0
60 Clinical Microbiology arid Infectiol1, Volume 6. Supplement 3. 2000
were th.: most common pathob'\:nic mixmn:. Almo. t all H.
1I1{lllen.::,u' str.uns wer.: nomypable and noncapsul. red and 16% were
f3-L1ctamase producer.; (PLP+) [2.7J. A PLP+ aerobe \vas [owld m
45'J{. of tOllllls examined and in 4(~Y., of adenoid sampb [2.71.
HAEMOPHILUS INFLUENZAE AND THE PATHOGENESIS OF
RECURRENT ACUTE TONSILLITIS
Kccently Wt" found additional eVlden e of an association
berween H. ;'lfl,ICllzal' and RAT; fine needle aspIration of the
torm] con: was perfOnllCd III 10 nomla] adult v Jumee wirh no
Imrory fRAT; no H. i,!f1l1t'1/zac Stmin w. i..~olated on culmre
[31. The: assOCI tion of H. i,!f1I1Pllzal' and the tonsil in RAT
r.med the possibility that H. i,!{llIl?lIzac has a role in the
pathogenesis oithe condition. Indirect pathogenicity may result
by p-lacranlaS<: production 18. 1or an addinonal pathogenic
mechanism may be implicated, u 11 mechanilms could
contnbme to pelllcillll1 treatment failure in pharyngoton illitis
111 the presence of underlymg tonsd pathology (RA1') and may
be a factor in ollie repor of penicillin treatment fuilurc in
pharyngotonsillitis 1101. Bactenal histamine production ;11 ";110
Ius been posrulated as a bacterial padlOgenic mechanism in the
pUIlIIIl of pancnts wlth CySIlC bbtosi> or chronic bronchitIS 111-
I~I and 111 adenoid,l hYlJerrrophy 115J. TIl.is raises the intriguing
po~ Ibiltry that III 5;'/1 hist, nun.: production 1I1 the tonsil by s me
~tr:lIl1S f H. i,!f1l1f11zar m. y ~til11ulat.: rclL-:ase of other
inflammatory mediators andlor i.nflammatory changes, thereby
contributmg to the pathogent'sis of itAT. In recent work. we
essed 178 J50lates of H. j'!f1/1wzac Including tomil isolates
(II =54) and pUNm ISOlates ell = I 13), for tll('ir ability t
produce hmanllne r1(1]. Histamine ass.'ys were aL~o pcrfonned
on t nsillar {lssue, nly five of tIle H. ;I!f1l1cIIZal' isolates
examined produced quanti~tivcly SIgnificant amounts of
histamine ill the ill "lIm assay. There was no correlation
between ti,e tonsil histamine conccntmnon and the presen e of
a luStamll1e producing H. il!f1l1l'11zar [16]. There was no
correl tion between tomi.! hist:lmil1l: concentration 31ld t n il
weight. over.ill ba terial coum and/or lev -I of fibro is 1161.
CONCLUSIONS
In recurrent a ute tonsillitis and in adenotOllsU.!ar disea e the
tonsil J5 a reservoir of H, ;'!f111mzaf. In children With
adcnolditi. or denotoJl.silljtis and hypertrophy of the adenoid.
a perna al b should be u cd in 1'1' 'feren e to throat \ ab
11\ sdecollg antimicrobi ] ther.lpy. In children and in 3dulL~
\ ith RA . the pemasal swab IS also 3. better predictor of core
tOllSll pathogens rban the supcrfi al th.r r wab, he
ociauon of H, ;IIjlllfllZIIC with RA i strikmg; however,
\ e havo:: Ii und no evidence that histamine production by H.
;,if/umzat h s • ny r Ie in rhe pathogene.~is f RAT. A ~LP+
aer be was fOUJld in ~S% of tonsils examined and i.n 40"/0 of
adenOId samples [2.61. hence penicillin and ampicillin are nm
appropnate empuic thenpy in recurrcnt acute tOil i!lius and in
chromc adenoidal or aden ron War infection. An altemative
antibIOtic th t is table ro P-Ia tamase a tivity hould be us(~d.
Po sible hoices include ra] ccph] sponn and carba e-
phelm. Th ·sc fincllllgs arc b. sed on srudies in children and
~dul with recurrent acute tonsillitis andlor adenoidal disea e.
Whether the findings are appll able to acute episodes of
ph ryngoron Wiris in patients \vithour \Il1dedYUlg ron i.!
pathology has 11 t yet been establilh ·d.
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